Targeting Cell Cycle Checkpoint Kinases to Overcome Intrinsic Radioresistance in Brain Tumor Cells.

Vlatkovic, Tijana; Veldwijk, Marlon R; Giordano, Frank A; Herskind, Carsten

Vlatkovic, Tijana; Veldwijk, Marlon R; Giordano, Frank A; Herskind, Carsten.

Afiliação

Vlatkovic T; Cellular and Molecular Radiation Oncology Lab, Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Veldwijk MR; Cellular and Molecular Radiation Oncology Lab, Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Giordano FA; Department of Radiation Oncology, Center for Integrated Oncology (CIO), University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.
Herskind C; Cellular and Molecular Radiation Oncology Lab, Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.

Cancers (Basel) ; 14(3)2022 Jan 29.

Article em En | MEDLINE | ID: mdl-35158967

Palavras-chave

ATM; ATR; CHK1; CHK2; WEE1; brain tumor; cell cycle checkpoints; checkpoint inhibitor; radiation therapy; radiosensitivity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google